Blood Boost for Patients With Heart Valve Infections
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Confirmed bacterial infection of the heart valve
- Low hemoglobin (red blood cell protein) at 6.0 mmol/L or below
- Stable condition after at least 10 days of IV antibiotics (and 7 days after surgery if you had valve surgery)
- No fever for at least 2 days and no active infection signs in recent blood tests
- Able to walk and complete a 6-minute walking test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples and medical information from patients with certain bloodstream infections to better understand why some develop a heart valve infection. The goal is to find out why some people get this complication and how to predict it.
This trial tests a procedure that uses a device to remove infected growths (vegetations) from the right side of the heart. It aims to reduce the risk of these growths breaking off and causing problems like blood infections or blockages.
This trial tests whether a combination of epoetin alfa (a medicine that boosts red blood cell production) and iron derisomaltose (an iron supplement) can safely treat anemia in people with sepsis or septic shock. It may help improve your energy and recovery.
This study tests whether intravenous iron can improve outcomes for people with non-ischemic heart failure and low ejection fraction who are also iron deficient. If you fit the criteria, you may receive iron infusions to see if it helps your heart function and symptoms.
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
This trial tests whether giving iron infusions after a TAVI procedure can help patients with iron deficiency feel better and improve their quality of life. It is for older adults who have low iron levels and have already had a successful valve replacement.
Hear when a new Infective Endocarditis (IE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.